Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04665206
Title Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors Enriched for Tumors With NF2 or mNF2 Gene Mutations
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Vivace Therapeutics, Inc
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS


No variant requirements are available.